Krister Kristianson

The impact of serum uric acid on cardiovascular outcomes in the LIFE study

Aud Høieggen, Michael H. Alderman, Sverre E. Kjeldsen et al. · Kidney International · 2004 · 476 citations

Medicine, Cardiology, Physiology +9

Effects of Losartan on Cardiovascular Morbidity and Mortality in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy

Sverre E. Kjeldsen, Björn Dahlöf, Richard B. Devereux et al. · JAMA · 2002 · 442 citations

Medicine, Cardiology, Pharmacology +17

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

Lars Lindholm, Hans Ibsen, Knut Borch‐Johnsen et al. · Journal of Hypertension · 2002 · 395 citations

Medicine, Cardiology, Pharmacotherapy +17

Characteristics of 9194 Patients With Left Ventricular Hypertrophy

Björn Dahlöf, Richard B. Devereux, Stevo Julius et al. · Hypertension · 1998 · 296 citations

Medicine, Cardiology, Pharmacotherapy +16

Stroke Reduction in Hypertensive Adults With Cardiac Hypertrophy Randomized to Losartan Versus Atenolol

Jorge R. Kizer, Björn Dahlöf, Sverre E. Kjeldsen et al. · Hypertension · 2004 · 102 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17